Glutathione is the most abundant intracellular antioxidant in the human body, a tripeptide of glutamine, cysteine, and glycine that neutralizes reactive oxygen species, regenerates vitamins C and E, and powers Phase II liver detoxification through glutathione S-transferase enzymes. Levels peak in youth and decline with age, chronic illness, alcohol use, acetaminophen exposure, poor sleep, and oxidative stress. Restoring glutathione has become a centerpiece of longevity and wellness medicine, but delivery route determines whether supplementation actually raises tissue stores.

Oral glutathione capsules and liposomal products dominate retail shelves, yet clinical pharmacology consistently shows poor systemic bioavailability from swallowed glutathione, stomach acid and intestinal peptidases cleave the tripeptide before meaningful absorption occurs. Glutathione push (rapid intravenous bolus in clinic settings) and injectable glutathione (subcutaneous or intramuscular home protocols) exist precisely to bypass that digestive barrier. Telehealth platforms including CLYR Health's glutathione program prescribe compounded injectable glutathione for patients whose providers determine parenteral antioxidant support fits their wellness goals.

What is a glutathione push?

In IV wellness clinics, a "glutathione push" typically means slow intravenous administration of reduced glutathione (GSH), often 600 mg to 2,000 mg, directly into a saline line or as a discrete bolus after other IV nutrients. The push delivers the full dose into systemic circulation within minutes, producing transient but significant plasma glutathione peaks that oral routes cannot replicate.

Clinic pushes are popular adjuncts to Myers' cocktail IVs, NAD+ infusions, and post-illness recovery protocols. Patients variously report improved energy, clearer skin tone, reduced brain fog, and faster recovery after travel or toxic exposures, though subjective benefit reports outpace rigorous RCT evidence for IV push protocols specifically. Push administration requires nursing oversight, vein access, and allergy monitoring; it is not a home DIY procedure.

Subcutaneous injection: the telehealth alternative

Home injectable glutathione, the model CLYR and similar platforms use, trades IV push immediacy for convenience and lower acuity. Compounded glutathione 200 mg/mL in sterile vials allows subcutaneous injection of measured doses (commonly 0.5 mL / 100 mg five times weekly) with insulin-syringe technique. Absorption is slower than IV push but still bypasses first-pass GI destruction entirely.

Subcutaneous protocols suit patients who want sustained antioxidant support without weekly clinic IV appointments. Plasma glutathione rises more gradually than with push dosing, but tissue repletion over weeks to months is the clinical target, not a single spike. Patients pair injectable glutathione with NAD+ therapy, Sermorelin, or post-GLP-1 oxidative stress recovery when providers coordinate multi-agent wellness stacks.

Mechanisms: what glutathione actually does

Antioxidant defense

Glutathione donates electrons to neutralize free radicals directly and serves as cofactor for glutathione peroxidase enzymes that reduce hydrogen peroxide and lipid peroxides. Without adequate GSH, mitochondria accumulate oxidative damage, impairing ATP production and accelerating cellular senescence. This is why glutathione is called the "master antioxidant": it sits at the hub of the redox network, not at the periphery.

Liver detoxification

Phase II conjugation in hepatocytes depends on glutathione binding to electrophilic toxins, heavy metals, mycotoxins, and drug metabolites (including acetaminophen conjugation that prevents hepatotoxicity). Depleted hepatic glutathione stores, common in NAFLD, alcohol use disorder, and chronic inflammatory states, reduce detox capacity and increase susceptibility to oxidative liver injury. Injectable repletion targets hepatocyte pools that oral supplements fail to reach.

Immune function

Immune cells require glutathione for lymphocyte proliferation, natural killer cell activity, and balanced inflammatory signaling. Low GSH correlates with impaired host defense in aging populations and chronic viral illness contexts studied in clinical literature. Parenteral supplementation aims to restore immunocompetent redox balance rather than "boost immunity" in vague wellness marketing terms.

Skin and melanin metabolism

Glutathione inhibits tyrosinase and shifts melanogenesis toward lighter pheomelanin relative to eumelanin, the biochemical basis for skin-brightening claims in dermatology-adjacent wellness practice. Injectable protocols report improved tone and reduced hyperpigmentation over four to eight weeks in anecdotal clinical experience; controlled trial data for cosmetic skin endpoints exist but are heterogeneous in dose and route.

Oral vs injectable: why route matters

Multiple studies demonstrate that oral glutathione, even liposomal formulations, produces minimal or inconsistent increases in blood glutathione compared with intravenous and intramuscular routes. The tripeptide is too large and too easily degraded for efficient enteral absorption. N-acetylcysteine (NAC) oral supplementation raises cysteine precursor availability and can support endogenous GSH synthesis indirectly, but it is not identical to delivering intact glutathione.

This pharmacologic reality explains the wellness market's pivot toward injections and IV pushes despite oral product convenience. Patients spending on oral glutathione without measurable effect may be candidates for prescriber-supervised injectable protocols, after appropriate screening, not as reflexive upselling.

Who might consider injectable glutathione

Injectable glutathione is not chemotherapy, not a COVID treatment, and not a substitute for treating underlying disease causing oxidative stress. It is adjunctive wellness pharmacology with a defined biochemical role.

Dosing, administration, and what to expect

CLYR's compounded protocol supplies two 5 mL vials at 200 mg/mL concentration monthly, enough for 0.5 mL subcutaneous injections five times per week (100 mg per dose). Providers may adjust frequency or volume based on tolerance and goals. Unlike IV pushes that deliver gram-scale boluses in single sessions, home injection spreads dosing for steadier tissue exposure.

Timeline expectations from clinical practice:

Results vary with baseline deficiency severity, concurrent lifestyle factors, and adherence. Glutathione is not a stimulant, patients should not expect immediate pharmacologic euphoria comparable to IV caffeine or B12 mega-doses.

Safety and contraindications

Compounded injectable glutathione is generally well tolerated. Most common adverse effects are mild injection-site erythema, stinging, or bruising. Rare hypersensitivity reactions (urticaria, bronchospasm) have been reported with IV administration, reason for slow push rates and clinic monitoring. Asthma history warrants caution with high-dose IV glutathione though subcutaneous home doses are lower acuity.

Pregnancy and breastfeeding lack robust safety data; most providers defer elective antioxidant injections unless clear maternal benefit outweighs unknown fetal risk. Patients on chemotherapy or immunosuppressive regimens should coordinate with oncology, high-dose antioxidant theory could theoretically interfere with pro-oxidant cytotoxic mechanisms, though clinical significance at wellness doses is debated.

Compounded medications are not FDA-approved for safety and efficacy review of the finished product; patients should use licensed 503A pharmacies with valid prescriptions, potency testing, and sterility certification, the standards described on CLYR's glutathione product page.

Glutathione push vs daily injection: choosing a format

IV push (clinic): Highest acute plasma peaks, nursing supervision, higher per-session cost, travel time, vein-access requirements. Best for patients wanting intermittent intensive sessions or combination IV nutrient stacks.

Subcutaneous home injection (telehealth): Lower per-dose intensity, daily or near-daily adherence, no clinic visits, provider-managed compounded vials shipped to door. Best for sustained repletion and patients prioritizing convenience over bolus intensity.

Some patients alternate both, clinic pushes during high-stress periods and home injections for maintenance. No head-to-head RCT compares long-term outcomes between strategies; choice is preference, cost, and prescriber judgment.

Pairing with other wellness therapies

Glutathione complements rather than replaces foundational health practices: sleep optimization, alcohol moderation, cruciferous vegetable intake (sulfur amino acid precursors), and exercise that stimulates endogenous antioxidant enzyme expression. In telehealth longevity stacks, glutathione often appears alongside NAD+ protocols, NAD+ supports mitochondrial energetics while glutathione protects those mitochondria from oxidative damage. Our broader glutathione master antioxidant explainer covers biochemistry in additional depth.

Bottom line

Glutathione push and injectable protocols solve the delivery problem that makes oral supplementation ineffective for most patients, bypassing digestive degradation to replenish the body's central antioxidant and detoxification molecule. IV pushes deliver rapid bolus peaks in clinical settings; subcutaneous home injections provide sustained telehealth-managed repletion at accessible monthly pricing. Neither is a miracle cure; both are mechanistically grounded tools for patients whose licensed providers identify antioxidant support as a rational wellness priority.

CLYR Health offers compounded glutathione injections with provider consultation, syringe supplies, and expedited shipping, a home-based alternative to recurring clinic IV pushes for patients who want master-antioxidant therapy with ongoing telehealth oversight.